Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2329267 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL6682528 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL28855151 | 0.83 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL17469834 | 0.83 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL7717518 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL17923981 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL7717519 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL10705113 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL12375335 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL17923882 | 0.81 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10ALOX15MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016016446-A1 | PROCESS FOR PREPARING 2-FLUOROPROPIONALDEHYDE | SANDOZ AG (CH) | 2016-02-04 | — | — | WO | claimed |
| US-20130216723-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2013-08-22 | — | — | US | claimed |
| EP-2203519-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | King Industries (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| WO-2009045466-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2009-04-09 | — | — | WO | claimed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | claimed |
| US-12537184-B2 | Electrochemical device and electronic device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2026-01-27 | — | — | US | disclosed |
| US-12494506-B2 | Nonaqueous electrolytic solution and energy device including the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-12-09 | — | — | US | disclosed |
| EP-4657604-A2 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | Ningde Amperex Technology Limited (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4404324-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-11-19 | — | — | EP | disclosed |
| US-12407022-B2 | Electrolyte and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2025-09-02 | — | — | US | disclosed |
| EP-4404323-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-07-23 | — | — | EP | disclosed |
| EP-3940843-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-07-23 | — | — | EP | disclosed |
| EP-0248554-A2 | Heterocyclic compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-12-09 | — | — | EP | disclosed |
| CN-86106984-A | New quinazoline derivant and preparation method thereof | — | 1987-05-20 | — | — | CN | disclosed |
| US-4605758-A | Preparation of α-arylalkanoic acids | SYNTEX PHARMACEUTICALS INTERNATIONAL LTD. (BM) | 1986-08-12 | — | — | US | disclosed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | disclosed |
| EP-0081993-A2 | Optically active alpha-substituted aryl ketones, their preparation and their use in preparing alpha-arylalkanoic acids | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1983-06-22 | — | — | EP | disclosed |
| US-4380661-A | HERBICIDES | HOFFMANN-LA ROCHE INC. (US) | 1983-04-19 | — | — | US | disclosed |
| US-4200587-A | HERBICIDES | HOFFMANN-LA ROCHE INC. (US) | 1980-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12537184-B2 | Electrochemical device and electronic device | LBR, LAMTOR3, CACNA2D1 | ALDH1A1 3398/4885LMNA 710/4885HSD17B10 1317/4885 |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | ALDH1A1 3647/4885LMNA 306/4885HSD17B10 2003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.